Keyron Medical Technology logo — Advanced medical devices for the treatment of metabolic dise...

Keyron Medical Technology

Advanced medical devices for the treatment of metabolic diseases

Founded 2016 10 employees Seed Total: $2.83M Medical Devices

General Information

Company Name Keyron Medical Technology
Founded Year 2016
Employees 10
Industries Medical Devices
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Keyron Medical Technology. To contact Keyron Medical Technology, visit keyron.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Keyron Medical Technology

Keyron Medical Technology is a UK- and US-based preclinical-stage medical device and technology platform company dedicated to developing advanced medical devices for the treatment of metabolic diseases. The company's patented ForePass® is designed to safely reverse type-2 diabetes, NASH, and obesity, with promising results demonstrated in animal studies published in The Lancet EBioMedicine. With upcoming clinical trials in South America and plans for further trials in the USA, Keyron has garnered support from influential figures in the metabolic diseases space. Multiple institutional investors in the USA and EMEA back the company. Founded in 2016, Keyron is currently seeking funding for a $7.5m Series A investment round, with Health Wildcatters contributing the most recent investment of $30.00K in the Seed Round on 06 September 2024. For investment opportunities, interested parties can reach out to the CEO, Carl D. Francis ([email protected]). Disclaimer: This is not a solicitation of investment.

Taxonomy: Metabolic Diseases, Technology Platform, Preclinical Research, Type 2 Diabetes Treatment, NASH Treatment, Obesity Treatment, Insulin Resistance, Clinical Trials, Investment Round, Institutional Investors, Healthcare Innovation, Patented Medical Devices, Expert Advisors

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $30.00K 1
Health Wildcatters
06 Sep 2024
Seed Round $2.80M 1
LIFTT
24 Dec 2021

Keyron Medical Technology Alternatives & Competitors

Keyron Medical Technology vs

Metamodix is dedicated to reducing the human and financial costs of Type 2 Diabetes. We have develop...

Venture round
3 employees
Health Care, Life Sciences
Keyron Medical Technology vs
Morphic Medical
Morphic Medical United States

Innovative therapies for type 2 diabetes and obesity, rooted in excellence since 2003.

Post-IPO Equity
50 employees
Biotechnology, Health Care
Keyron Medical Technology vs
Fractyl Health
Fractyl Health United States

Dedicated to novel therapies that can sustain long term weight management.

Series F
104 employees
Biotechnology, Health Care

FAQ About Keyron Medical Technology

Advanced medical devices for the treatment of metabolic diseases
Keyron Medical Technology was founded in 2016.
Keyron Medical Technology operates in Medical Devices. Its work centres on Metabolic Diseases, Technology Platform, Preclinical Research and Type 2 Diabetes Treatment.
Keyron Medical Technology has approximately 10 employees.
Keyron Medical Technology has completed 2 funding rounds, raising a total of $2.83M. The latest funding stage is Seed.
Top alternatives and competitors to Keyron Medical Technology include Metamodix, Morphic Medical, Fractyl Health, Ascendant Biotech Corporation, Endogenex. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Keyron Medical Technology and Metamodix are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Keyron Medical Technology, https://bouncewatch.com/company/keyron-medical-technology, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes